132 results have been found
July 9, 2020
Grifols starts commercializing TAVLESSE® in Europe, diversifying its medicines portfolio
June 26, 2020
Grifols discloses transfers of value made to European healthcare professionals and health-sector organizations in 2019
June 11, 2020
Grifols starts production of its hyperimmune immunoglobulin as a potential passive immune therapy against COVID-19
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?